SK Bioscience Co Ltd
KRX:302440
SK Bioscience Co Ltd
KRX:302440
Price:
39 450
KRW
0.64%
Market Closed
Market Cap:
3.1T
KRW
Cash Flow Statement
Cash Flow Statement
SK Bioscience Co Ltd
SK Bioscience Co Ltd
Currency: KRW
Millions
TTM
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
32 890
|
74 815
|
127 626
|
181 052
|
355 139
|
341 021
|
334 335
|
278 676
|
122 452
|
80 378
|
18 276
|
45 890
|
22 318
|
22 868
|
27 435
|
(43 274)
|
(50 117)
|
|
| Depreciation & Amortization |
16 527
|
20 900
|
25 398
|
18 015
|
18 775
|
20 206
|
22 146
|
24 462
|
27 236
|
29 702
|
31 789
|
33 517
|
34 765
|
35 624
|
36 175
|
36 706
|
49 225
|
|
| Other Non-Cash Items |
8 612
|
22 568
|
(68 779)
|
58 545
|
130 619
|
113 100
|
218 725
|
85 401
|
36 221
|
24 420
|
(14 689)
|
42 307
|
7 969
|
(1 503)
|
(247)
|
(110 671)
|
(166 631)
|
|
| Cash Taxes Paid |
249
|
2 596
|
5 977
|
8 627
|
8 987
|
51 623
|
104 019
|
103 301
|
104 210
|
68 261
|
24 759
|
23 172
|
25 639
|
17 209
|
4 365
|
5 025
|
4 658
|
|
| Cash Interest Paid |
4 055
|
5 037
|
5 866
|
3 717
|
3 407
|
3 151
|
3 010
|
2 949
|
2 681
|
2 403
|
2 201
|
1 602
|
1 397
|
1 163
|
927
|
974
|
3 567
|
|
| Change in Working Capital |
62 195
|
156 877
|
176 416
|
23 555
|
32 060
|
(243 385)
|
(357 673)
|
(219 631)
|
(310 868)
|
(182 266)
|
(159 119)
|
(110 101)
|
(35 705)
|
14 314
|
71 813
|
63 630
|
39 503
|
|
| Cash from Operating Activities |
120 224
N/A
|
275 160
+129%
|
260 661
-5%
|
281 168
+8%
|
536 594
+91%
|
230 943
-57%
|
217 533
-6%
|
168 908
-22%
|
(124 958)
N/A
|
(47 766)
+62%
|
(123 743)
-159%
|
11 613
N/A
|
29 346
+153%
|
71 302
+143%
|
135 175
+90%
|
(53 610)
N/A
|
(128 020)
-139%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(10 198)
|
(16 182)
|
(25 882)
|
(31 154)
|
(44 470)
|
(62 088)
|
(85 003)
|
(87 287)
|
(76 489)
|
(60 150)
|
(38 687)
|
(44 482)
|
(50 295)
|
(118 350)
|
(117 459)
|
(137 611)
|
(172 225)
|
|
| Other Items |
(97 895)
|
(1 197 030)
|
(1 155 395)
|
(1 141 247)
|
(1 377 471)
|
(10 138)
|
(76 044)
|
(63 501)
|
349 136
|
222 862
|
396 108
|
280 642
|
5 017
|
(985)
|
(41 261)
|
280 653
|
225 789
|
|
| Cash from Investing Activities |
(108 093)
N/A
|
(1 213 212)
-1 022%
|
(1 181 278)
+3%
|
(1 172 401)
+1%
|
(1 421 940)
-21%
|
(72 226)
+95%
|
(161 046)
-123%
|
(150 789)
+6%
|
272 647
N/A
|
162 712
-40%
|
357 421
+120%
|
236 160
-34%
|
(45 279)
N/A
|
(119 335)
-164%
|
(158 720)
-33%
|
143 043
N/A
|
53 564
-63%
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
0
|
984 196
|
983 256
|
983 256
|
983 256
|
(30)
|
2 618
|
2 618
|
2 618
|
0
|
0
|
0
|
398
|
0
|
0
|
0
|
75 680
|
|
| Net Issuance of Debt |
(1 237)
|
(24 260)
|
(24 801)
|
(24 042)
|
(24 247)
|
(2 298)
|
35 283
|
(14 509)
|
(22 485)
|
(69 821)
|
(147 934)
|
(100 966)
|
(95 464)
|
29 953
|
67 882
|
177 255
|
181 266
|
|
| Other |
(301)
|
(929)
|
(930)
|
(930)
|
(628)
|
0
|
0
|
0
|
0
|
0
|
5 484
|
5 484
|
5 484
|
0
|
0
|
0
|
(4 467)
|
|
| Cash from Financing Activities |
(1 539)
N/A
|
959 006
N/A
|
957 526
0%
|
958 284
+0%
|
958 380
+0%
|
(2 328)
N/A
|
37 901
N/A
|
(11 891)
N/A
|
(19 867)
-67%
|
(68 112)
-243%
|
(142 450)
-109%
|
(95 482)
+33%
|
(89 583)
+6%
|
35 835
N/A
|
68 280
+91%
|
177 653
+160%
|
252 479
+42%
|
|
| Change in Cash | ||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
22
|
21
|
39
|
0
|
(562)
|
4 096
|
6 826
|
7 692
|
7 253
|
4 441
|
3 084
|
(2 321)
|
7 653
|
|
| Net Change in Cash |
10 592
N/A
|
20 954
+98%
|
36 909
+76%
|
67 050
+82%
|
73 056
+9%
|
156 410
+114%
|
94 427
-40%
|
6 228
-93%
|
127 259
+1 943%
|
50 929
-60%
|
98 055
+93%
|
159 984
+63%
|
(98 262)
N/A
|
(7 757)
+92%
|
47 819
N/A
|
264 765
+454%
|
185 676
-30%
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
110 026
N/A
|
258 978
+135%
|
234 779
-9%
|
250 014
+6%
|
492 124
+97%
|
168 855
-66%
|
132 530
-22%
|
81 620
-38%
|
(201 448)
N/A
|
(107 916)
+46%
|
(162 430)
-51%
|
(32 869)
+80%
|
(20 949)
+36%
|
(47 048)
-125%
|
17 716
N/A
|
(191 220)
N/A
|
(300 245)
-57%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
